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The unique capability of germ cells to give rise to a new organism, allowing the transmission of primary genetic information from
generation to generation, depends on their epigenetic reprogramming ability and underlying genomic totipotency. Recent studies
have shown that genome-wide epigenetic modiﬁcations, referred to as “epigenetic reprogramming”, occur duringthedevelopment
of the gamete precursors termed primordial germ cells (PGCs) in the embryo. This reprogramming is likely to be critical for the
germ line development itself and necessary to erase the parental imprinting and setting the base for totipotency intrinsic to this
cell lineage. The status of genome acquired during reprogramming and the associated expression of key pluripotency genes render
PGCs susceptible to transform into pluripotent stem cells. This may occur in vivo under still undeﬁned condition, and it is likely
at the origin of the formation of germ cell tumors. The phenomenon appears to be reproduced under partly deﬁned in vitro
culture conditions, when PGCs are transformed into embryonic germ (EG) cells. In the present paper, I will try to summarize the
contribution that epigenetic modiﬁcations give to nuclear reprogramming in mouse PGCs.
1.Introduction
Nuclear reprogramming is generally deﬁned as the process
reverting the nucleus of a diﬀerentiated cell to a pluripotent
or totipotent state. The formation in culture of embryonic
stem (ES) or epiblast embryonic stem (EpiES) cells from
the inner cell mass (ICM) of the blastocyst or the epiblast
of postgastrulating embryo, respectively, of embryonic germ
(EG) cells from primordial germ cells and more recently
of induced pluripotent stem (iPS) cells from diﬀerentiated
somatic cells are examples of nuclear reprogramming in
vitro. As far as I know, in mammals, physiological nuclear
reprogramming leading to totipotency occurs only at the
onset of embryogenesis when the genome of the zygote and
subsequently of the early blastomeres acquires totipotency.
This reprogramming requires a genome status of gametes
that originates from early processes of nuclear reprogram-
ming occurring at the beginning of gametogenesis in the pri-
mordial germ cells (PGCs), the embryonic precursors of the
gametes. The identiﬁcation of the timing and the underlying
molecular mechanisms of this early process in PGCs oﬀers
precious information not only about gametogenesis and
reproduction, but also on the secretes of stemness and clues
for a number of pathologies including cancer development.
Nuclear reprogramming involves a variety of genetic and
epigenetic modulators. This latter include DNA methylation
and a variety of posttranslational histone modiﬁcations.
The emerging small regulatory RNA molecules can be also
regarded as epigenetic regulators but will not be discussed
here (for reviews, see [1, 2]).
During the last decades, with the relevant contribution
of the ideas and the inspiration of the late Anne McLaren,
her work and that of her disciples, important advancements
have been done on the basic principles and mechanisms
governing nuclear reprogramming in PGCs, mainly in the
mouse. The present review, is an attempt to summarize
the emerging information relative to the contribution of
epigenetic changes, in particular DNA methylation and
histone modiﬁcation, to nuclear reprogramming in mouse
PGCs.2 Stem Cells International
2. DNA Methylation
In mammals, methylation to the 5 position of the cytosine
pyrimidine ring represents the major epigenetic modiﬁ-
cation of DNA (for reviews, see [3, 4]). It occurs pre-
dominantly in regions containing high frequency of the
sequence cytosine phosphate guanine (CpG), termed CpG
islands. Transcription repression is generally associated to
methylation of CpG islands located into or near gene
promoters(5ﬂankingregion).Inalmostallcelltypes,tissue-
speciﬁc genes generally undergo demethylation of CpG
islands speciﬁcally in their tissue of expression. In contrast,
housekeeping genes contain CpG islands unmethylated in all
cells.
Mammalian genome encodes three DNA methylases
(DNMTs): the maintenance methyltransferase DNMT1 and
the de novo methyltransferases DNMT3a and DNMT3b.
Moreover, DNMT3L, another member of the DNMT3 fam-
ily, does not possess DNA methyltransferase activity, but it
is required for DNMT3a and DNMT3b functions. Once im-
posed by de novo DNMTs, DNA methylation is transmitted
to the cell progeny by DNMT1 as long as demethylation pro-
cesses take place.
DNA methylation/demethylation can be divided into
global (genome wide) and speciﬁc (when just speciﬁc DNA
sequences are methylated/demethylated). While it is thought
thatglobalmethylationstate,termedmethylome,isrelatively
stable in diﬀerentiated cells, dynamic changes of methy-
lome occur during cell diﬀerentiation. Global demethylation
occurs at two speciﬁc times during development, namely, at
the onset of embryogenesis and during the PGC develop-
ment and is associated to nuclear reprogramming; speciﬁc
demethylation seems typical of somatic cells responding to
particular signals.
DNA demethylation can be achieved passively by the
failure of the maintenance methylation by DNMT1 during
DNA synthesis at the S stage of the cell cycle or by the active
removal of methyl groups from cytosine, independently of
DNAreplication.ActiveDNAdemethylationcanbeachieved
basically by (1) direct removal of methyl group, (2) the
removal of entire DNA patch followed by ﬁlling with new
nucleotides by nucleotide excision repair (NER), and (3)
the removal of methylated base either by direct removal of
methylcytosine, or through previous cytosine modiﬁcation.
This latter can occur for example by 5-meC deamination
to produce thymine (T) or hydroxylation to produce 5-
hydroxymethylcytosine(5-hmeC)followedbytheremovalof
T by T/G mismatch or 5-hmeC by several ways and the inser-
tion of unmethylated cytosine using base excision repair
(BER) machinery (for a review, see [5]). As discussed later,
inmammals,activeDNAdemethylationseemsmostlytoem-
ploy mechanisms referred in point (3).
3. Histone Modiﬁcations
Histone modiﬁcations provide an additional and complex
source of epigenetic modiﬁcation of the genome. Many en-
zymes that regulate histone modiﬁcations, mainly occurr-
ing in their amino terminal tail, have been identiﬁed.
They include histone acetyltransferases (HATs), deacetylases
(HDACs), methyltransferases (HMTs), and demethylases
(HDMases). Phosphorylation, ADP ribosylation, sumoyla-
tion, and ubiquitination are other possible histone modiﬁ-
cations, but they will not be discussed here since, as far as I
know, there is no evidence about their involvement in PGC
nuclear reprogramming.
Generally, the histones are acetylated and deacetylated
on lysine (K) residues. These reactions are catalyzed by
enzymes with histone acetyltransferase (HAT) or histone
deacetylase (HDAC) activity. In most cases, histone acety-
lation enhances gene transcription while histone deacety-
lation represses transcription. Histones may be methy-
lated on either lysine (K) or arginine (R) residues by
the addition of one, two, or three methyl groups. The
process is catalyzed basically by three families of HMT
enzymes: the protein arginine N-methyltransferase (PRMT)
family, the lysine methyltransferases of the Su (var) 3–
9, enhancer of zeste, trithorax (SET)-domain, or the dis-
ruptor of telomere silencing 1 (DOT1/DOT1L) protein
families (for a review, see [6] ) .T h er e g u l a t i v ec o n s e -
quence of histone methylation on transcriptional activa-
tion or repression depends on the site and degree of
methylation.
Among the best-characterized mediators of histone
methylation are protein complexes of the polycomb (PcG)
and trithorax (TRXG) groups containing a SET domain
(for a review, see [7]). PcG and TRXG proteins form
multimeric complexes that bind to DNA and direct post-
translational histone modiﬁcations. They are critical reg-
ulators of gene expression, repressors (PcG), or activators
(TRXG), necessary for cell fate speciﬁcation and main-
tenance. PcG proteins catalyze preferentially two distinct
histone modiﬁcations: trimethylation of lysine 27 of histone
3 (H3K27me3) by polycomb repressive complex 2 (PRC2)
and mono-ubiquitination of lysine 119 H2A (H2AK119ub1)
by PRC1. H3K27 is trimethylated by the enhancer of
zeste 2 (EZH2), which is the catalytic subunit of PRC2
that includes noncatalytic subunits suppressor of zeste 12
(SUZ12) and embryonic ectoderm development (EED).
EEDs may also interact with HDACs and mediate repres-
sive histone de-acetylation. Some TRXG proteins methylate
histone H3 at lysine 4 (H3K4), a transcription permissive
mark, while others posses demethylation or acetylation
activities.
Elements of the histone code and some combinatorial
pattern of histone marks are shown in Table 1. A partic-
ularly well-studied histone combination is the contempo-
rary presence of the repressive H3K27me3 with the active
H3K4me3, termed a “bivalent domain.” Bivalent domains
maintain genes in a state that is repressed but ready for
a c t i v a t i o na n dh a v eb e e nr e c e n t l yd i s c o v e r e di nE Sc e l l s
(see below). Genomic regions that are associated with gene
silencing, including transposons and repetitive elements,
frequently possess the heterochromatin marks H3K9me3
and H4K20me3.
Histone methylation was believed to be a quite sta-
ble modiﬁcation. After the discovery of histone demethy-
lases (HDMases), histone methylation is now consideredStem Cells International 3
Table 1: Summary of the main histone code in mammalian cells.
Type of
modiﬁcation
Histone
H3K4 H3K9 H3K14 H3K27 H3K79 H4K20 H2BK5 H3K4 +
H3K27 H3K9 + H4k20
Mono-methylation Activation Activation Activation Activation Activation Activation
Dimethylation Activation Repression Repression Activation
Trimethylation Activation Aepression Repression Repression Bivalent Heterochromatin
Acetylation Activation Activation
a dynamic modiﬁcation. Two kinds of histone lysine
demethylases have been identiﬁed, including lysine speciﬁc
demethylase 1 (LSD1) and Jumonji C (JmjC) domain family
proteins.Peptidyl-argininedeiminase4(PAD4/PADI4)anta-
gonizes methylation on arginine residues by converting
mono-methyl arginine in histone H3 and H4 to citrulline.
4. Basic Principle/sof Nuclear
ReprogramminginPGCs
Beforeenteringintothespeciﬁcthemesofthepresentreview,
a brief description of the PGC development in the mouse
embryo is needed. For more detailed information excellent
reviews are available on this topic [8–12].
The PGC precursors (about 6 cells) are speciﬁed in the
proximal epiblast in the posterior region of the embryo
around 6.25 days post coitum (dpc) [13]. While proliferating,
PGC precursors move through the posterior primitive
streak into the extraembryonic mesoderm at the basis of
allantois. Here, around 7.25dpc, a founder population of
about 40PGCs is determined [14]. Thereafter, these PGCs
migrate and enter the gonadal ridges from 10.5dpc onwards.
By 13.5dpc, PGCs enter meiotic prophase in the female
becoming primary oocytes and mitotic arrest in the male
gonad becoming prospermatogonia. In the present review,
we will refer as early or pregonadal PGCs between 7.5 and
10.5dpc before entering into the gonads, and late PGCs
between 10.5 and 13.5dpc after arrival and colonization of
the gonadal ridges.
Three basic principles govern nuclear reprogramming
in PGC development: ﬁrst, the need to inhibit somatic cell
lineage pathways, second, the establishment of a transcrip-
tionregulatorynetworknecessarytomaintaindiﬀerentiation
plasticity, and third, the resetting of the genome epigenetic
status to eliminate epimutations and erase the parental
imprinting. These conditions are likely to be interrelated and
require both genetic and epigenetic modulators. Alltogether,
they are intrinsic to the germ cell diﬀerentiation pattern
itself and necessary for setting the germ cell genome towards
totipotency.
Theinhibitionofallcelldiﬀerentiationpathways,includ-
ing the germ cell lineage, and the presence of transcription
regulatory network for pluripotency are typical features of
the embryonic stem (ES) cells, derived from the culture of
the inner cell mass (ICM) of the blastocyst. In addition,
ES cells posses self-renewal, the capability of dividing while
maintaining their undiﬀerentiated and pluripotent status
for long periods. PGCs, however, at least in the mouse, do
not possess a long-lasting self-renewal capability, are lineage
determined and do not manifest pluripotency in conditions
in which ES cells normally do (i.e., chimeras [15, 16]). This
means that in PGCs, some stem cell characteristics coexist
withspeciﬁcdiﬀerentiationpathways,auniquefeatureofthe
germ cell lineage.
Before their ﬁnal diﬀerentiation into oocytes in females
and prospermatogonia in males, in several mammalian
species, including humans, PGCs can be induced to deviate
their normal diﬀerentiation pathway and give rise to true
stem cell lines similar to ES cells termed embryonic carci-
noma (EC) cells in vivo, and embryonic germ (EG) cells in
vitro (for a review, see [17]). This process super imposes
a nuclear reprogramming on PGCs that basically inhibits
their germline diﬀerentiation pattern, confers them the
self renewal capability and allows their latent pluripotency
to manifest in suitable environments. This process oﬀers
a formidable model to understand the origin of certain
tumours from germ cells and perhaps from other cell types
and interesting clues about important aspects of stemness
that will be discussed in a separate section below.
As reported above, when PGCs ﬁnally diﬀerentiate into
oocytes,averyspecializeddiﬀerentiationpathwaycentredon
meiosis begins. During meiosis prophase and up to meiotic
block at the diplotene stage around birth, the genome
of the oocyte is organized in condensed chromosomes,
and all players of the transcription regulatory network
for pluripotency (i.e., Oct4, Nanog,a n dSox2 genes) are
silenced. Thereafter, when the oocyte is included within
a primordial follicle and meiosis is blocked, the genome
remains relatively quiescent until the growing phase begins
in selected primordial follicles. This signs the beginning
of intense transcription activity and the reexpression of
transcription factors typical of pluripotency (i.e., OCT4,
SOX2). It is likely that during the oocyte growing phase,
other genome changes complete nuclear reprogramming
towards totipotency, but very little is known about. At the
end of the maturation process, oocytes posses pluripotency
as shown by their capability to give rise to teratomas, a kind
oftumourscomposedofmultiplecelltypesderivedfromone
or more of the three germ layers [18].
In the male germ cell lineage, PGCs give rise to
prospermatogonia, also called, gonocytes, which within the
forming testicular cords of the fetal testis progressively
undergo mitotic arrest. These cells remain quiescent until4 Stem Cells International
after birth reenter a mitotic cell cycle. Through unknown
processes, a subpopulation of gonocytes give rise to a true
stem cell populations the spermatogonia stem cells (SSCs)
able to self-renewal and to give rise to waves of proliferating
spermatogonia that enter meiosis as spermatocytes. It is
now clear, that SSCs not only posses self renewal but, like
PGCs, have an intrinsic pluripotency. In fact, under certain
culture conditions, diﬀerent from those causing PGCs trans-
formation into EG cells, SSCs obtained from prepubertal
or adult testes can give rise to pluripotent stem cell lines
termed germ-like stem cells (GSCs, [19]), multipotent adult
germline stem cells (maGSCs, [20]), and multipotent adult
spermatogonial-derived stem cells (MASCs, [21]). There is
no information about the mechanisms responsible for the
nuclear reprogramming of SSCs into such stem cell types.
5.TimingandMechanismsof
Nuclear Reprogramming inPGCs
During development, nuclear reprogramming in PGCs
occurs at several steps: when their precursors are speciﬁed,
during their determination, the migratory phase, and after
theirarrival into the gonadalridges. Itis not knownif ittakes
placeundertheinﬂuenceofthediﬀerentmicroenvironments
or if it occurs following the activation of an autonomous
program or both. It is known, however, that it is associated
to epigenetic changes involving wide progressive DNA
demethylation and several histone modiﬁcations. Moreover,
complex genome-wide transcription dynamics are strictly
related to these epigenetic modiﬁcations.
It is to be pointed out that the study of epigenetic mod-
iﬁcations in PGCs mainly during pregonadal stages is made
diﬃcult by the small numbers of available cells. For exam-
ple, methods as immunoprecipitation of methylated DNA
(MeDIP) and chromatin immunoprecipitation technologies
(ChIP) cannot be used with pregonadal PGCs. Changes in
DNA methylation in pregonadal PGCs have been so far
analysed only by immunohistochemistry using antibodies
against 5-meC. In late PGCs, both immunohistochem-
istry and bisulphite methods followed by PCR have been
used.
5.1. DNA Demethylation in Pregonadal PGCs. Early studies
indicated that mouse PGCs isolated from the gonadal
ridges possess relatively under methylated DNA [22, 23].
It is now known that just after speciﬁcation, PGCs have
a relatively high genome methylation status similar to
that of the surrounding epiblast cells and that during the
subsequent stages, they undergo various rounds of passive
and active DNA demethylation [24]. This means that PGC
precursorsdo not escapethe progressive de novo methylation
of extraembryonic and embryonic lineages that follows
the loss of genomic methylation occurred at the onset of
embryogenesis between the zygote and blastocyst stages.
According to immunohistochemistry, a genome-wide
DNA demethylation begins in a portion of PGCs at around
8dpc,soonaftertheirdetermination[24].Thisseemstoarise
mostly passively. In fact, at this time, several conditions in
PGCs favour passive demethylation. They are proliferating,
and the expression of three main methyltransferases, the
maintenancemethyltransferaseDNMT1,thedenovomethyl-
transferaseDNMT3a, and DNMT3b, is repressed [25, 26].In
addition, the expression of Np95/Uhrf1,oneoftheDNMT1’s
cofactors, is also repressed [27]. It appears that the key
transcription factors governing the germ-cell speciﬁcation,
BLIMP1/PRDM1 and PRDM14 (for a review, see [9, 28,
29]), are directly or indirectly involved in this repression
[27]. DNMT3L that at later stages will be essential for the
establishment of the primary imprinting both in male and
female germ cells and DNA methylation of transposons in
meiotic male germ cells [30], is not expressed in PGCs [31].
Subsequently,between8.5and9.5dpc,whenPGCsbegin
tomigratetowardsthegonadalridgesandbecometemporar-
ily mitotic quiescent, demethylation extends to the most
part of PGCs [25]. At this time, because mitotic quiescence
and the DNMT1 reexpression, demethylation is likely to be
mostly active [25, 27]. Accumulating evidence supports the
possibility that active DNA demethylation in PGCs employs
DNA repair-mediated pathways [32, 33]. Such evidence
actuallycomesfromstudiescarriedoutingonadalPGCs(see
below),andnoinformationisavailableforpregonadalPGCs.
In a recent review, Mochizuki and Matsui [34] speculated
that the expression in pregonadal PGCs of the growth
arrest and DNA-damage-inducible protein 45 (GADD45)
[27] and the DNA deaminase (AID) [35], suggest their
involvement in active DNA demethylation in such cells. In
this model, it is assumed that deamination by AID converts
5-meC into thymine and gives rise to a T-G mismatch
followed by the insertion of unmethylated cytosine using
BER; GADD45 might recruit AID and the DNA glycosidase
methyl-CpG-binding domain protein 4 (MBD4) to 5-meC
[36].
In this context of passive and active DNA demethyla-
tion, imprinted genes, repetitive DNA elements including
retrotransposons and satellite centromeric sequences and
some germ-cell speciﬁc genes (i.e., Vasa, Gcna1, Dazl, Scp3),
remain largely protected from demethylation. An important
unresolved question is how such selective epigenetic modi-
ﬁcations can occur. At the onset of embryogenesis, in early
PGCs, DNMT1 and STELLA might be responsible for such
protection [37, 38].
Which might be the function of DNA demethylation at
these stages? The wide-genome demethylation starting in
pregonadal PGCs might favor the maintenance of one of
the major processes of PGC speciﬁcation, the inhibition of
diﬀerentiation pathway towards somatic cell lineages (for a
review, see [9, 28, 29]). At the same time, demethylation
might favour the expression of pluripotency-related and
germ cell-speciﬁc genes occurring just after PGC speciﬁ-
cation. Many pluripotency-related genes (i.e., Oct4, Nanog,
Sox2, Rex1, Fbx15) and some germ cell-speciﬁc genes (i.e.,
Stella, Nanos3) are expressed speciﬁcally in PGCs at fate
determination [26, 27]. Hypomethylation of promoters
characterizes the expression of three key pluripotency genes
such as Oct4, Nanog,a n dSox2 in cell lines. Moreover, the
suppression of Oct4 and Nanog expression associated to
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in diﬀerentiating ES cells [39–41]. In the case of Oct4, de
novo methylation of CpG islands mediated by DNMTs serves
to stabilize the repression. In fact, during ES diﬀerentiation,
the interaction of GCNF with the methyl-CpG-binding
proteins MBD2 and MBD3 initiates Oct4 repression. The
lysine-9 trimethylation of histone H3 mediated by the G9a
histone methyltransferase also contributes to such early
repression [42–44]. Due to the limited cell numbers, no such
information are available for PGCs. However, a recent report
has showed CpG hypomethylation of the ﬂanking region
of Oct4 during PGC-like cell induction from epiblast stem
cells (EpiSCs) [45]. Similarly, the germ-like speciﬁc Stella
and the pluripotency-related Rex1 and Fbx15 genes become
hypomethylated in the CpGs of the ﬂanking regions in PGC-
like cells induced from EpiSCs in which hypermethylation of
these CpG islands is associated to lack of expression of these
genes [45].
Finally, demethylation events in female pregonadal PGCs
might be involved in the initial reactivation of the inactive X.
It is now known, that, contrary to the previous suggestions,
reactivationoftheinactiveXalreadybeginsinnascentfemale
PGCs and proceeds gradually [46]. The mechanism for
X chromosome inactivation involves a nontranslated RNA
transcript of the X-inactive speciﬁc transcript (Xist)g e n e
locatedontheXchromosomeinactivationcentre(XIC)[47].
The control of Xist expression appears to be due to DNA
methylation on the inactive X chromosome since the gene
control region is unmethylated on the inactive X chromo-
some and methylated on the active X chromosome which
does not express Xist [48]. X reactivation is accompanied by
a progressive decrease of the Xist transcripts, reexpression of
X-linked genes, and, quite surprisingly, by demethylation of
the Xist promoter [49]. It seems, therefore, that reactivation
of the inactive X chromosome is accompanied by epigenetic
mechanisms other than Xist methylation.
5.2. DNA Demethylation in Gonadal PGCs. After 9.5dpc,
PGCs reenter the cell cycle and begin the colonization of
the gonadal ridges. Around 13.5dpc, in female, they enter
meiosis as primary oocytes while in the male they undergo
mitotic arrest in G2. During this period, PGCs undergo a
further wave of DNA demethylation [24, 32]. The bulk of
such demethylation takes place quite rapidly in about 24h,
mostly between 11.5 and 12.5dpc, and despite the presence
in the PGC nucleous of DNMT1. Thus suggesting that it
mainly occurs by active demethylation. Such process pref-
erentially aﬀects single copy-imprinted, and nonimprinted
genes, whereas demethylation of repetitive elements (espe-
cially of intracisternal A-particle (IAP) and long interspersed
repeated (LINE-1) elements) is more protracted [49–51].
Genomic imprinting is a phenomenon by which certain
genes are expressed in a parent-of-origin-speciﬁc manner. It
is a typical epigenetic process that involves DNA methylation
in order to achieve monoallelic gene expression (for a review,
see [52, 53]). The erasure of imprinting in PGCs ensures
the establishment of sex-speciﬁc new imprinting during
the following stages of gametogenesis. On the other hand,
the protracted demethylation of repetitive elements may be
necessary to prevent dangerous transcriptional activation
of the transposable elements, since this would increase the
risk of germline mutations through deregulation of adjacent
genes and through transposition.
When PGCs reach the gonadal ridges several, germline
speciﬁc-genes are upregulated such as Mvh, Dazl, Gcna1,
Mageb4,a n dScp3.I nDmnt1-deﬁceint mice, however, pre-
matureexpressionofthesegenesoccursinpregonadalPGCs,
indicating the possible importance of DNA demethylation
for the expression of these genes [54].
Chromatin remodelling in the PGC nuclei seems another
consequence of DNA demethylation. In fact, carefully obser-
vation by Hajkova et al. [55] showed that DNA demethyla-
tion precedes chromatin remodelling.
Recent studies have began to reveal the mechanisms
possibly involved in the active demethylation in gonadal
PGCs. Popp et al. [32], using unbiased sequencing of bisul-
phite-treated DNA by next generation sequencing (BS-Seq)
method, investigated genome-wide DNA methylation in
13.5dpc mouse PGCs. This analysis revealed that DNA from
maleandparticularlyfemalePGCs,washighlyunmethylated
(approximately 15% and 7% methylation of total DNA,
resp.) compared to methylated DNA levels in sperm (about
85%), ES cells (about 80%), the foetus (about 75%), and
placenta (about 45%). When this analysis was repeated with
tissues obtained from mice depleted of the DNA deaminase
(AID), it was found that while in most tissues examined,
AID deﬁciency did not alter the level of DNA methylation;
in PGCs a signiﬁcant increase in methylation was observed
(about 5% and 10%, resp.), thus, indicating a loss of DNA
demethylation in these cells. In this model, deamination
by AID converts C into T and gives rise to a glycosylase-
media-ted T-G mismatch followed by the insertion of
unmethylated cytosine by BER. These results support the
notion that in PGCs active AID-mediated demethylation
occurs but also that other factors are involved. Another
study has shown that at the time of DNA demethylation
in 11.5dpc PGCs, there is an upregulation of transcripts
of genes involved in BER, including Parp1, Ape1,a n d
Xrcc1. This increase was asso-ciated to the presence in the
PGC nuclei of XRCC1, a primary component of BER,
together with PARP1 and APE1 [33]. The authors favour
the possibility that BER is activated by the conversion of
5-mC to 5-hmC, for which the enzymes of the ten-eleven
translocation (TET) family are responsible, followed by the
excision of this latter by a speciﬁc glycosylase; Tet1 expres-
sion was found indeed at high levels in 11.5dpc PGCs
[33].
The abundant presence of PARP1 and PAR polymers,
a product of PARP1, in the PGC nuclei during DNA de-
methylation [33] (our unpublished observations) and the
multifunctional actions of members of the PARP family on
the genome (for a review, see [56]) suggest a role of this
enzyme beyond than in BER. Surani and Hajkova [28] sug-
gested that PARP1 might be responsible for the higher-order
chromatin changes and the loss of chromocenters in PGCs.
In addition, a direct involvement of PARP1 in DNA methyla-
tion is possible (for a review, see [57]). In this regard, high
levels of PAR might inhibit DNMT1 during the about-ﬁve6 Stem Cells International
cellcyclesoccurringinPGCsbetween10.5and13.5dpc[58],
the period of the imprinting erasure.
5.3. Histone Modiﬁcations in Pregonadal PGCs. Using im-
munohistochemistry with antibody speciﬁc for methylated
or acetylated histones, it has been shown that the
staining patterns of the PGC precursors and PGCs
around 7.5dpc for the modiﬁcations H3K4me2, H3K4me3,
H3K9Ac, H3K9me1, H3K9me2, H3K9me3, H3K27me2, and
H3K27me3 were indistinguishable from those of their som-
atic neighbours. It is of note that the lineage-restricted
PGC precursors in female embryos showed prominent
accumulation of H3K27me3 in a single spot, most likely
the inactive X chromosome [59, 60]. This suggests that the
initiation of the X-inactivation process in the germline is
similar to that in the somatic lineages. Chuva de Sousa Lopes
et al. [61], using immunohistochemistry for H3K27me3
and an X-located green ﬂuorescent protein (GFP)-carrying
transgene, actually conﬁrmed that BLIMP1-positive PGC
precursors were subjected to X inactivation like their somatic
neighbors.
Around 8.0dpc, a number of global histone changes
begin in PGCs. These include erasure of H3K9me2, a repres-
sive mark with high stability, and upregulation H3K27me3,
a repressive mark with apparent plasticity. The ﬁrst mod-
iﬁcation occurs despite the presence of G9a (also known
as EHMT2), a histone methyltransferase with a strong
HMTase activity towards H3-K9. The absence of glucagon-
like peptide-2 (GLP-2 or EHMT1) necessary to form the
active G9a-GLP2 complex and/or competition with the acti-
vation mark H3K9ac probably prevent G9a action. On the
other hand, the enhancement of H3K27me3 might be due
to the action of the EZH2, a polycomb group enzyme [24,
25, 55]. Interestingly, Seki et al. [25] found that these histone
changes occur progressively in migrating PGCs, most likely
depending on their developmental maturation. Moreover,
they observed that before or concomitant with the erasure
of H3K9m2, PGCs enter G2 arrest, which continued until
they acquire high levels of H3K27me3. Notably, although
the overall levels of nuclear H3K27me3 were increasing,
female PGCs gradually lose H3K27me3 mark on the silent
X chromosome [61]. Following the onset of H3K9me2
erasure, PGCs show also repression of RNA polymerase
II-dependent transcription that is gradually relieved after
the release from the G2 arrest and the acquisition of high
levels of H3K27me3. The precise signiﬁcance of repression of
RNAP II-dependent transcription and G2 arrest is currently
unknown. Although both events seem to occur through
mechanisms independent from the histone modiﬁcation
state of PGCs [25], they are likely to be necessary for their
eﬃcient epigenetic reprogramming.
Histone modiﬁcations in pregonadal PGCs include at
least two other changes: the enrichment of H3K4me2
and H3K4me3, generally associated to actively transcribed
euchromatin, and the symmetrical methylation of arginine
3 on histones H4 and H2A (H4/H2AR3me2s), a repressive
mark conferred by a complex between the transcriptional
repressor BlIMP1 and protein Arginine methyl transferase
5 (PRMT5). This latter mark is likely important for
maintaining the PGC lineage during migration [62]. So
far, only the DEAH (Asp-Glu-Ala-His) box polypeptide 38
(Dhx38) gene encoding the pre-mRNA-splicing factor ATP-
dependent RNA helicase PRP16 has been identiﬁed as target
of this repressive mark [62]. Finally, another repressive mark
H3K9m3 that speciﬁcally marks centromeric heterochro-
matin as well transposon and repetitive elements, is main-
tained relatively constant during this period up to 11.5dpc.
In female PGCs, the accumulation of repressive H3K27me3
gradually diminishes speciﬁcally on inactivated X [25]. This
latter is accompanied by displacement of PcG repressor pro-
teinsEEDandSUZ12fromtheXdespitethepresenceofhigh
levels of these proteins in the nuclei of PGCs between 9.5 and
11.5dpc [63]. As far as I know, no other information about
the presence and role of PcG proteins in mammals PGCs are
available.
These observations demonstrate that within euchro-
matin regions PGCs erase a repressive mechanism oper-
ated by H3K9me2 and replace it with H3K27me3 and
H4/H2AR3me2s. The ﬁrst modiﬁcation may allow greater
genome plasticity, the latter is possibly necessary to prevent
diﬀerentiation towards somatic cell lineages. Transcrip-
tionally permissive H3K4 methylations and H3K9ac are
progressively increased. These marks might cooperate in
events, discussed above, regarding DNA methylation, as
the upregulation of pluripotency and germ cell-speciﬁc
genes and might reﬂect the reprogramming of the PGC
genome eventually necessary for totipotency at the onset of
embryogenesis. Such chromatin status partly resembles that
of ES cells and probably favours the transformation of PGCs
into the pluripotent EG and EC cells (see below).
5.4. Histone Modiﬁcations in Gonadal PGCs. The ﬁrst sign
of histone modiﬁcation in gonadal 11.5dpc PGCs is a
rapid loss of linker histone H1 accompanied by “loosen-
ing” of the chromatin and loss of chromocenters [55]. A
concomitant downregulation of H3K9me3, H3K27me3, and
H4/H2AR3me2s, and the disappearance or redistribution of
factors are associated with facultative or constitutive hete-
rochromatin, such as heterochromatin protein 1α (HP1α),
HP1β, and HP1γ, the homologue of α-thalassaemia/mental
retardation syndrome X-linked (ATRX) protein, and the
polycomb-like protein M33 (also known as CBX2). Tran-
scriptionally permissive H3K4 methylations and H3K9ac are
also lost [24, 55]. Thus, it seems that the genome during
PGC reprogramming undergos a phase of removing most
epigenetic marks. It seems that this is achieved, at least in
part, by histone replacement, potentially involving the his-
tone chaperone and nucleosome assembly protein 1 (NAP1)
[55].
In Figure 1, the main epigenetic changes accompanying
mouse PGC development are schematically represented.
6.ComparingPGCandESCellEpigenetics
As reported above, some of the principles of nuclear repro-
gramming in pregonadal PGCs are common with thoseStem Cells International 7
Figure 1: PGC development and associated epigenetic events in the mouse embryo. Changes in DNA methylation (DNAm) and histone
modiﬁcations are represented by diﬀerent shading intensity.
governing the formation and the maintenance of the undif-
ferentiated state of ES cells, in particular the generalized
inhibition state of somatic cell lineage pathways associated
with the expression of key pluripotency genes. At the same
time, however, PGCs show limited or absent self-renewal
capability, and are committed to the germline lineage in
which a unique DNA methylation resetting centred on the
erasing of imprinting occurs. By considering the status of
DNA methylation and the histone code in ES cells and how
they are involved in the maintenance of pluripotency and
self-renewal as well in the diﬀerentiation pathways of these
cells, some clues about the contribution of these epigenetic
changes and the underlying controlling mechanisms of the
nuclear reprogramming in PGCs can be achieved.
Likesomaticcells,EScellsshowhighgloballevelsofDNA
methylation, with about 60–80% of all CpG dinucleotides
being methylated [64]. Although the global mCpG content is
similar, the distribution of the mark is quite diﬀerent from
that of any other somatic cell type. In ES cells, promoters
containing high level of CpG have low DNA methylation
levels,whereaslowCpGpromotersarerelativelyhighmethy-
lated [64–66]. CpG-rich promoters are almost invariably
associated with the active H3K4me3 mark. Some of these
promoters control constitutively expressed housekeeping
genes, but others corresponding to developmental regulators
also contain the repressive H3K27me3 mark. Methylated low
CpG promoters are marked neither by H3K4me3 nor by
H3K27me3 and are mostly repressed in ES cells [64–66].
Interestingly, the presence of two active XX chromosomes
makes DNA globally hypomethylated both at repetitive and
unique sequences [67].
From the information reported above on DNA methyla-
tioninPGCs,twomaindiﬀerenceswithEScellsareapparent.
First, a progressive general demethylation was associated to
PGC development in comparison to a more stable global
methylation status of ES cells. Second, a DNA demethylation
activity of PGCs was coupled to the erasure of the genome
imprinting absent in ES cells. More detailed analyses of
similarities and diﬀerences in DNA methylation have been
performed only between ES cells and PGC-derived EG cell
lines. Similarly to PGCs, EG cells derived from 11.5–12.5dpc
PGCs were shown to be grossly hypomethylated (mainly
in EG cells with both active XX, [68]) and possess strong
demethylation activity [69]. As for methylation of imprinted
genes, EG cells derived soon after PGC speciﬁcation (early
EG cells) showed heterogeneous DNA methylation patterns
in comparison with EG cells derived after PGC colonisation
of the gonadal ridges (late EG cells) which were uniformly
hypomethylated at these sites with the expected exception of
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of ES and EG cells performed with diﬀerent methods
and on diﬀerent lines revealed distinct DNA methylation
patterns at various CpG islands [70] while substantial
similarity in the methylation patterns of promoters with
intermediate level of CpG content (between 2% and 9%)
in which most dynamics changes in methylation occur
[71].
Taken together, these results indicate that cell pluripo-
tency, except for hypomethylation of the promoter of key
pluripotency genes, cannot be associated with a particular
status of global DNA methylation. Methylation of diﬀerent
CpG sites may vary in pluripotent cells probably depending
on the diﬀerent characteristics of their pluripotency. In ad-
dition, in the germ cells, the dynamics of DNA methylation
isuniquebecausefunctionaltootherprocessdiscussedabove
suchastheremovalofepimutationsanderasingoftheparen-
tal imprinting.
All four DNMTs are highly expressed in ES cells. While
DNMTs are essential for embryonic development [72], loss
of DNA methylation by ablation of single or various DNMTs
does not inﬂuence the ES cell viability and self-renewal
but impairs their diﬀerentiation properties (for a review,
see [73]). Demethylating agent, 5-azacytidine (5-AZA), was
reported to reverse the diﬀerentiation status of ES cells
forming embryoid bodies (EBs) back to undiﬀerentiated ES
cells [74]. Both Oct4 and Nanog are devoid of CpG islands
in promoter regions [75], whereas the promoter region
of Sox2 is CpG rich. The promoter regions of Oct4 and
Nanog are hypomethylated in ES cells but acquire signiﬁcant
methylation during cell diﬀerentiation process. However,
the promoter region of Sox2 gene is almost completely un-
methylated in both ES cells and diﬀerentiated cells.
Alltogether, theseobservations suggestthatDNA methy-
lation in ES cells is passively and actively maintained at
high levels by DNMT1, but loci of key pluripotent genes
are maintained unmethylated. DNA methylation is not suf-
ﬁcient to repress diﬀerentiation nor is crucial for self-
renewal and pluripotency. Diﬀerentiation towards certain
cell lineages requires that a portion of DNA methylation
is maintained. None of these suggestions is incompatible
with the wide-genome demethylation accompanying PGC
development and in contrast with the principles of their
nuclear reprogramming. Despite high DNA methylation
level, ES cells show that an open chromatin structure and
active chromatin domains are widespread [76].
The histone code is probably the main responsible for
the unique genome state of ES cells. Analyses of genome-
wide chromatin-state maps have recently shown that many
genesin mouseES cells,including severalthatareinvolved in
diﬀerentiation, are characterized by an unusual combination
of histone marks, termed the “bivalent domains.” This
includes H3K9ac and methylated H3K4, which are marks
of active chromatin, and H3K27me3, which is typical of
silent chromatin [77]. In most non stem cells, genes have
either active or repressive marks, but not both. A similar
epigenetic proﬁle was also identiﬁed by others at genes
encoding developmentally important transcription factors
[78, 79]. These authors showed that loss of these epigenetic
marks was correlated with diﬀerentiation and proposed that
the presence of both active and repressive marks allowed
diﬀerentiation-speciﬁc genes in ES cells to be repressed but
also to be primed for activation when the right signals are
received. Interestingly, about half of the identiﬁed bivalent
domains in ES cells have binding sites for at least one of
the three key pluripotency-associated transcription factors
OCT4, NANOG, and SOX2.
As reported above, histone acetylation depends on the
activities of several HATs or HDACs while histone methy-
lation/demethylation is catalyzed by families of HMTs and
HDMases, respectively.
In general, it appears that ES cell diﬀerentiation is
accompanied by a global increase of histone acetylation
except in speciﬁc loci of key pluripotent genes [80], followed
by diﬀerentiation-speciﬁc deacetylation [81]. In line with
this notion, increased level of acetylation, induced by the
inhibition of HDACs by trichostatin (TSA), results in a
rapid repression of pluripotent genes and the induction
of diﬀerentiation-associated genes [82, 83]. A sustained
inhibition of HDACs favours diﬀerentiation towards certain
cell lineages such a cardiomyocytes and neurons [83].
Recently, a number of general global-wide analyses have
identiﬁed large numbers of binding sites for the HMTs of
the PcG family across the ES cell genome [84, 85]. The
PcG proteins are essential for early mammalian embryo
development [86–89], but not for maintaining ES cell
pluripotency. PcG mutant ES cells can still self-renewal,
maintain normal morphology, and express pluripotent genes
[90–93]. In addition, although the PcG knockout ES cells
do not diﬀerentiate eﬃciently into the three germ layers,
they can still contribute to their formation [90, 92, 93].
However, loss of individual PRC proteins in ES cells results
in increased expression of diverse lineage-associated genes
and spontaneous diﬀerentiation [90, 92, 93], an eﬀect that
is more pronounced in ES cells carrying targeted deletions of
both Prc1 and Prc2 genes [93]. Notably, the promoter regions
that are occupied by PcG proteins in ES cells contain the
“bivalent” H3K4me3 and H3K27me3 marks [76, 78]. These
genes were also found to be generally transcriptionally silent.
ThissuggeststhatPcGproteinshelptomaintainthesilencing
of these genes in undiﬀerentiated ES cells. Because some
results suggest that the repressive H3K27me3 mark can be
heritably transmitted to daughter cells to maintain speciﬁc
gene expression programs [94–96], the expression of devel-
opmentally regulated genes would necessitate the removal of
the H3K27me3 mark. Demethylation of H3K27me3/me2 by
theUTXandJMJD3mightbethemechanismbywhichPcG-
repressed promoters are activated [96–98].
Alltogether, these results suggest that epigenetic regula-
tion may be dispensable for maintaining ES cell identity.
It appears that epigenetic mechanisms of gene silencing
contribute to the overall stability of pluripotency but are
downstream in this setting. ES cell characteristics might
principallyberegulatedbytranscriptionfactorsandintrinsic
molecular pathways activated by exogenous signals. Epige-
netic chromatin-based repressive and activating modiﬁers
may serve transcriptional corepressor and coactivating func-
tions in this process. On the other hand, the stability of
a given cell state relies on the silencing of genes encodingStem Cells International 9
players of other cell states. In this context, the major ES
cell transcription factors appear to activate both programs
of self-renewal and pluripotency through an autoregulatory
circuit. In some cases, they could possess also the ability to
alter chromatin structure [99–102].
As in ES cells, the activity of key pluripotency tran-
scription factors such as OCT4, NANOG, and SOX2 is
likely crucial for nuclear reprogramming in the emerging
PGCs. Before this, however, the ﬁrst process governing
nuclear reprogramming in PGCs seems exerted by the
repressiveactionofthetranscriptionfactorBLIMP1/PRDM1
on somatic Hox genes [103]. This is closely followed by
the expression of PRDM14 that together with BLIMP1 is
critical for the activation of pluripotency genes [104]. In
PGCs, these events, however, do not activate a long-lasting
self-renewalcapability. This likely requires the contemporary
expression of other transcription factors (i.e., c-MYC, KLF4)
and the activity of intracellular signalling pathways (i.e.,
STAT3) necessary for self-renewal. At the same time, in
PGCs, the expression of genes and activities of molecular
pathways speciﬁc of the germline could restrain the self-
renewal circuit. BMPs, namely, BMP-4, BMP-2, and BMP-
8b and probably adhesion molecules such as E-Cadherin
and Fragilis are exogenous signals regulating such initial
reprogramming (for review, see [8–12]). In this contest,
as discussed above, epigenetic changes might favour and
stabilize the germ cell diﬀerentiation programme. Moreover,
inPGCs,theyservetobeginthegenomeresettingforthesex-
speciﬁc gamete imprinting and towards totipotency.
The ﬁrst detectable epigenetic modiﬁcation (the begin-
ning of genome-wide DNA demethylation, erasure of
H3K9me2, upregulation H3K27me3, H3K9ac, H3K4me2,
and H3K4me3 and H4/H2AR3me2s), are seen around the
period when PGCs are determined 7-8dpc, suggesting that
they exert as in ES cells, transcriptional corepressor, and
coactivating functions. At least in part, these modiﬁca-
tions appear to be directly or indirectly activated by the
BLIMP1/PRMT5 complex and PRDM14 [27, 103, 104].
Interestingly, the pattern of histone marks established
in pregonadal PGCs with the contemporary presence of
H3K27me3 and H3K4 methylations and H3K9ac partly
resembles the “bivalent domain” code of ES cells, thus,
suggesting that this chromatin structure might represent the
base for the maintenance of latent PGC pluripotency at this
stage. How HATs or HDACs and HMTs and HDMases parti-
cipate to the histone modiﬁcations in PGCs is not known.
In fact, apart from the observations reported above that the
progressive X reactivation in female PGCs is accompanied by
displacement of PcG repressor proteins EED and SUZ12 and
that high levels of these proteins are present in the nuclei of
PGCs between 9.5 to 11.5dpc [62], no other information
about the presence and role of PcG proteins in mammals
PGCs are yet available.
7.Reprogramming on Reprogramming:
EGCellFormation
During migration and for some time after the arrival into
the gonadal ridges, PGCs from several mammalian species,
including humans, can be induced in vitro to deviate
from their normal diﬀerentiation pattern and transform
or transdiﬀerentiate into EG cells, cell lines showing self-
renewal, and pluripotency characteristics very similar to ES
cells (for a review, see [17]).AfterPGCsbegintodiﬀerentiate
into oocyte and prospermatogonia, around 12.5dpc in the
mouse, they lose this capability. As reported above, however,
descendents of PGCs, the SSCs in male and the mature
oocytes in female, show again the capability to give rise
multipotent stem cells in culture and teratomas in vivo,
respectively, indicating the presence of latent pluripotency
like PGCs.
The formation of EG cells from PGCs means that a new
nuclear reprogramming can be superimposed on the ongo-
ing nuclear reprogramming until a certain developmental
stages. This basically renders PGCs able to manifest their
latent pluripotency and acquire self-renewal.
Early studies showed that a fraction of pregonadal mouse
PGCs (around2–20% of 8.5dpc PGCs) transformed into EG
cellswhen they were cultured invitro onto cell monolayers in
serum-supplemented medium and in continuous presence
f o r7 – 1 0d a y so ft h r e ee x o g e n o u sg r o w t hf a c t o r s ,n a m e l y ,
the kit ligand (KL), leukemia inhibitory factors (LIFs), and
basic ﬁbroblast growth factors (bFGFs) [105, 106]. Each of
the growth factors required for EG cell derivation activates
unique signal transduction pathways partly overlapping in
the downstream eﬀectors. Several studies by us and others
have established that KL and LIF act as antiapoptotic factors
and comitogens to control PGC survival and proliferation
whereas bFGF appeared mostly mitogenic for PGCs (for a
review, see [107]). This latter notion was also supported by
the observation that in the growth factors cocktail, bFGF can
be replaced with potent PGC mitogens such as retinoic acid
(RA) or agents that activate cAMP such as forskolin (FRSK)
[108, 109]. More recently, it has been shown that bFGF
and partly KL can be also substituted by hyperactivation
of AKT [110], a potent survival and proliferative stimulus
downstream phosphoinositide 3-kinase (PI3K). This can be
activated by a number of growth factors including bFGF
and KL. In line with this, EG cell colony formation was
enhanced in PGCs depleted of phosphatase and tensin
homolog (PTEN) which antagonizes the actions of PI3K
[109, 111]. Thus, sustained PGC survival and proliferation
in culture appear a prerequisite for EG cell formation.
Atthesametime,geneticandepigeneticeventsofnuclear
reprogramming must take place. It has been proposed
that following bFGF-binding upregulation of the FGFR-3
receptor and its translocation into the nucleus is a crucial
eventforinhibitingPGCdiﬀerentiationPGCsandbeginning
their reprogramming in culture as EG cells [16]. Exposure
of PGCs to bFGF for just the ﬁrst 24 hours of culture is
necessary and suﬃcient for EG cell formation providing that
LIF is present in the medium after 1 day of culture [16, 31].
Since as reported above, bFGF can be substituted by RA,
FRSK, or hyperactivated AKT, several signalling pathways
in collaboration with LIF can induce the reprogramming of
cultured PGCs.
A number of genetic events involved in such process have
been identiﬁed. A key early event during the culture of PGCs10 Stem Cells International
in the presence of bFGF is the downregulation of Blimp1 and
theconsequentupregulationofitstargetgenesDhx38,c-Myc,
and Klf4 [31]. While Dhx38 repression has been proposed to
be necessary for maintaining early germ cells [62], the latter
representstwoofkeytranscriptionfactorsknowntopromote
reprogramming of somatic cells to the pluripotent state of
the iPS cells [112–115].
It has been proposed that the AKT promoting action
on EG cell derivation is exerted through two targets: direct
phosphorylation and inhibition of GSK-3 and inhibition of
p53 activity mediated by GSK-3-dependent phosphorylation
of MDM2, an E3 ubiquitin ligase for p53. In line with these,
both inhibition of GSK-3 and absence of p53 favour the EG
cell derivation [110, 116]. GSK-3 participates in various sig-
naling pathways, such as WNT/β-catenin, Hedgeog proteins,
Notch,andproteinkinaseA(PKA)signals.However,itseems
unlikely that the activation of the WNT/β-catenin, usually a
consequence of the GSK-3 inhibition, plays a role in nuclear
reprogramming of PGCs in culture. In fact, the suppression
of WNT/β-catenin signalling by GSK-3 appears to be neces-
sary for normal PGC proliferation [117]. The p53 deﬁciency
in the cultured PGCs, that only partly, however, substitute
bFGF, might favour the acquisition of dediﬀerentiate state.
Recent studies have identiﬁed the roles of p53 in suppressing
pluripotency and cellular dediﬀerentiation. In this context,
p53 suppresses the self-renewal of embryonic stem cells and
blocks the reprogramming of somatic cells into iPSCs by
inducing the expression of hundreds of genes, leading to
cell cycle arrest, apoptosis, and senescence (for a review, see
[118]). These new studies support the idea that molecules
critically involved in genome stability function as not only
guardians of the genome, but also barriers to pluripotency. It
is interesting to note that, as reported above, in addition to
p53 deﬁciency also that of PTEN, another important tumour
suppressor, greatly facilitates EG cell derivation.
Whatever are the GSK-3 targets, its inhibition is alone
not suﬃcient for PGC conversion. In fact, it requires the
contemporaryinhibitionoftheextracellularsignal-regulated
kinases (ERKs). Notably, EG can be obtained from 8.5dpc
PGCs in serum-free culture in 2i-LIF medium supplemented
only with LIF and containing an inhibitor of GSK-3 and
of the upstream kinase MAP ERK kinases (MEK1/2) [119].
Recently, it has been shown that the mouse ES cells can
be self-renewal in basal medium if autocrine-activated
ERK signalling is eliminated and GSK-3 activity reduced.
Moreover, the 2i-LIF medium allowed eﬃcient derivation
and expansion of ES cells [119].
Finally, trichostatin (TSA), an inhibitor of HDACs not
only replaced bFGF but it also accelerated and increased
the eﬃciency of PGC reprogramming into EG cells [31].
This indicates that epigenetic modiﬁcation is crucial for
reprogramming PGCs in culture and suggests that it is
the chromatin organization that prevents establishing the
OCT4, NANOG, and SOX2 circuit of active pluripotency
and prolonged self-renewal in such cells. These results are
diﬃcult to reconcile with a previous study by Maatouk and
Resnick [120] in which the authors reported that under
similar culture conditions TSA and 5-AZA as well accel-
erated the diﬀerentiation of 8.5dpc PGCs as estimated by
a more rapid downregulation of alkaline phosphatase and
upregulation of GCNA1 after three days of culture. A
possible explanation might be found in the fact that nuclear
reprogramming leading to dediﬀerentiation actually occurs
only in a subpopulation of PGCs, as reported above around
2–20% of 8.5dpc PGCs, and/or that in the short period of
culture analysed by Maatouk and Resnick [120], the drugs
might induce temporary changes in the expression of some
genes irrelevant for nuclear reprogramming.
In this context, it is likely that LIF action is necessary
in the longer time for stabilizing and maintaining the
full reprogramming process after the main reprogramming
events are occurred. In fact, LIF is not required during
day one of culture when bFGF or hyperactivated AKT
exerted their action [16, 31, 108], but its presence is oblig-
atory after this time in any EG cell derivation conditions.
Notably, pregonadal PGCs do not express STAT3 ([121], our
unpublished observation), the transcriptional activator that
mediates the LIF-dependent self-renewal and maintenance
of pluripotency in ES cells, but it appears after 4 days of
culture [31], likely as a consequence of the previous nuclear
reprogramming.
In Figure 2, the hypothetical multistep process of the
nuclear reprogramming of PGCs in culture is shown.
8. Concluding Remarks
Nuclear reprogramming occurs progressively in PGCs dur-
ing migration and gonadal ridge colonization. Epigenetic
mechanisms of gene silencing and activation contribute to
such nuclear reprogramming, but they are likely down-
stream genetic players. In this regard, PGC characteristics
might principally be regulated by transcription factors
whereas the most part of the epigenetic modiﬁcations are
mainly associated with resetting the genome for subse-
quent parental imprinting on the gametes and regaining
zygote/blastomeres totipotency. Nuclear reprogramming in
nascent PGCs centred on BLIMP1/PRDM1- and PRMD14-
dependent inhibition of somatic cell lineages and activation
of core transcriptional circuits of pluripotency is activated
by growth factors of the BMP family. Future studies will
clarify whether epigenetic changes are also controlled by
transcription factors and/or exogenous signals or occur by
intrinsic regulators. Improvements of epigenomic analysis
technologies are needed to identify the whole normal epige-
nomic setting of PGCs and epigenomic changes occurring
in mutants and disease conditions. The possibility to apply
single-cell gene expression analysis to PGCs (see, [103]) will
probably facilitate such studies.
A further nuclear reprogramming can be superimposed
on PGCs in vivo and in vitro leading to their transformation
into pluripotent stem cells. Reprogramming of PGCs in vitro
only requires the addition of exogenous growth factors and
provides important insights into the molecular mechanisms
regulating the stemness characteristics. The expression in
PGCs of key pluripotency transcription factors such as
OCT4, NANOG, and SOX2 is not suﬃcient to confer themStem Cells International 11
Figure 2: PGC transformation in EG cells. The process is schematically subdivided in to three main steps: rapid 1 day reprogramming
processes involving TSA-induced epigenetic modiﬁcations and resetting of various gene and intracellular signalling pathways, a mid-time
(2–4 days) establishment of a LIF/STAT3-dependent self-renewal circuit, and the formation of EG cell colonies requiring 7–10 days of cul-
ture. Various growth factors and compounds controlling each steps are reported; a cell monolayer producing KL and other not identiﬁed
compounds is also represented.
a long lasting self-renewal capability and a manifest pluripo-
tency. This might be a consequence of the lack of expression
of other transcription factors (i.e., c-MYC, KLF4) and
intracellular signalling pathways (i.e., STAT3) necessary for
self-renewal. The derivation of EG cells in vitro from PGCs
is actually triggered by downregulation of BLIMP1/PRDM1
and activation of c-Myc and Klf4 as well the establishment
of a LIF/STAT3 signalling. Interestingly, epigenetic modiﬁca-
tions induced by a TSA-dependent DNA iper-acetylation or
inhibitionofERKandGSK-3pathwaysareabletoreplacethe
reprogramming action of growth factors on PGCs. Besides
highlighting the crucial relevance of such processes for
nuclear reprogramming, these results suggest that the devel-
opment of the germline relies on the maintenance of a def-
inite epigenetic state and the activity of certain intracellular
pathways.
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